Sequential serum creatinine, 4-variable MDRD eGFR, haemoglobin and haematocrit profiles. (A) serum creatinine and (B) eGFR (4v MDRD). Renal function was similar in the EPO and placebo treated patients, with no significant differences. (C) Haemoglobin and (D) Haematocrit during the first 3 months post-transplant. Haematocrit levels were similar in the EPO and placebo treated patients with no significant differences. EPO treated group placebo group Data expressed as mean ± SEM, ANOVA.